GéoMégA Resources Inc. (Geomega) (GMA)

About GéoMégA Resources Inc. (Geomega)

Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. The company markets EPKINLY and TEPKINLY for adult patients with relapsed or refractory (R/R) diffuse large b-cell lymphoma (DLBCL), large B-cell lymphoma, and follicular lymphoma (FL); and Tivdak for adult patients with recurrent/metastatic cervical cancer with disease progression on or after chemotherapy. It is also developing Epcoritamab for R/R DLBCL and FL, first line DLBCL and FL, B-cell non-Hodgkin lymphoma, R/R chronic lymphocytic leukemia and Richter's syndrome, and aggressive mature B-cell neoplasms in pediatric patients; tisotumab vedotin for solid tumors; Acasunlimab for solid tumors and non-small cell lung cancer (NSCLC); Rinatabart Sesutecan for platinum resistant ovarian cancer and solid tumors; GEN1059, GEN1055, and GEN1057 for solid tumors; and GEN1286 for advanced solid tumors. In addition, the company offers DARZALEX/DARZALEX FASPRO for multiple myeloma (MM) and light-chain Amyloidosis; RYBREVANT for NSCLC; TECVAYLI and TALVEY for R/R MM; Kesimpta for Relapsing multiple sclerosis; and TEPEZZA for thyroid eye disease. Further, it is developing Amivantamab for recurrent/metastatic head and neck cancer, and advanced or metastatic colorectal cancer; Amlenetug for multiple system atrophy; Inclacumab for vaso-occulsive crises in sickle cell diseases; and Mim8 for hemophilia A. The company has a collaboration agreement with AbbVie Inc., Pfizer Inc., BioNTech SE, Johnson & Johnson, Medarex, Inc., Bristol Myers Squibb Corporation, Lundbeck A/S, Amgen Inc., Novo Nordisk A/S, and argenx. Genmab A/S was incorporated in 1998 and is headquartered in Copenhagen, Denmark.

Headquarters: Copenhagen · Employees: 3119 · Website: https://www.genmab.com

Related Macro Trends

• Rare Earth & Critical Minerals

Product categories

• Rare Earth Elements
• Heavy Rare-Earth Separation

Competitors of GéoMégA Resources Inc. (Geomega)

• ASM International NV (ASM)
• China Northern Rare Earth (Group) High-Tech Co.,Ltd (600111.SS)
• Xiamen Tungsten Co., Ltd. (600549.SS)
• Lynas Rare Earths Limited (LYC.AX)
• MP Materials Corp. / DE (MP)
• Defense Metals Corp. (DEFN)
• China Rare Earth Resources And Technology Co., Ltd. (000831.SZ)
• USA Rare Earth, Inc. (USAR)
• Guangsheng Nonferrous Metals Co., Ltd. (600259.SS)
• ENERGY FUELS INC (UUUU)
• Iluka Resources Limited (ILU.AX)
• Critical Metals Corp. (CRML)

Frequently asked questions about GéoMégA Resources Inc. (Geomega) (GMA)

What is GéoMégA Resources Inc. (Geomega) (GMA)?

GéoMégA Resources Inc. (Geomega) (GMA) is a publicly traded company in the Healthcare sector (Biotechnology). Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.

Who are GéoMégA Resources Inc. (Geomega)'s main competitors?

Competitors of GéoMégA Resources Inc. (Geomega) (GMA) tracked by Macroplane include ASM International NV (ASM), China Northern Rare Earth (Group) High-Tech Co.,Ltd (600111.SS), Xiamen Tungsten Co., Ltd. (600549.SS), Lynas Rare Earths Limited (LYC.AX), MP Materials Corp. / DE (MP), Defense Metals Corp. (DEFN), China Rare Earth Resources And Technology Co., Ltd. (000831.SZ), USA Rare Earth, Inc. (USAR), and 4 more.